SCHEMBL3324714

SCHEMBL3324714

O=S(=O)(O)c1ccc(/N=N/c2ccccc2)c(Nc2c(-c3ccccc3)ccc3ccccc23)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.43
▸ GAA P10253 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ POLB P06746 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ SENP2 Q9HC62 3/20 0.42
▸ SENP1 Q9P0U3 3/20 0.42
▸ SENP7 Q9BQF6 3/20 0.42
▸ SENP3 Q9H4L4 2/20 0.42
▸ SUMO2 P61956 2/20 0.42
▸ SUMO1 P63165 2/20 0.42
▸ CYP1A2 P05177 3/20 0.41
▸ HIF1A Q16665 3/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ PTPRA P18433 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3329717 0.82 SENP2 (0.49) KMT2AGAAMAPTMAPK1TDP1
SCHEMBL3329715 0.82 SENP2 (0.49) KMT2AGAAMAPTMAPK1TDP1
SCHEMBL2776374 0.78 ATIC (0.48) KMT2AGAAMAPTMAPK1TDP1
SCHEMBL6819284 0.72 CTRB1 (0.66) KMT2AGAAMAPTMAPK1TDP1
SCHEMBL5267969 0.69 SENP2 (0.50) KMT2AGAAMAPTMAPK1TDP1
SCHEMBL5267972 0.69 SENP2 (0.50) KMT2AGAAMAPTMAPK1TDP1
SCHEMBL27771162 0.69 POLB (0.66) KMT2AGAAMAPTMAPK1TDP1
SCHEMBL14413250 0.68 CYP1A2 (0.65) KMT2AGAAMAPTMAPK1TDP1
SCHEMBL15400423 0.68 ALDH1A1 (0.44) KMT2AMAPTTDP1CYP1A2HIF1A
SCHEMBL28711292 0.67 POLB (0.64) KMT2AMAPTTDP1POLBCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107984936-B Reusable writing material and preparation method thereof 吉林大学 2022-05-06 — — CN disclosed
US-20100119561-A1 Compositions Having a Performance Indicator AMCOL INTERNATIONAL CORPORATION (US) 2010-05-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100119561-A1 Compositions Having a Performance Indicator STRA6, EXOSC5, CD63 KMT2A 4817/4885GAA 205/4885MAPT 2836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback